Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
---|
08/09/2011 | CA2616940C Novel serine protease bssp2 |
08/09/2011 | CA2567177C Genetically engineered cells for therapeutic applications |
08/09/2011 | CA2500209C Method of preparing gene expression profile |
08/09/2011 | CA2481731C Secreted and transmembrane polypeptides and nucleic acids encoding the same |
08/09/2011 | CA2450179C Identification of stat6 modulators using ncoa-1/stat6 interaction |
08/09/2011 | CA2447921C Methods for protecting allogeneic islet transplant using soluble ctla4 mutant molecules |
08/09/2011 | CA2444960C Method of improving dough and bread quality |
08/09/2011 | CA2438092C Ttk in diagnosis and as a therapeutic target in cancer |
08/09/2011 | CA2422748C Talaromyces xylanases |
08/09/2011 | CA2422078C High efficiency cardiac gene transfer |
08/09/2011 | CA2412534C New compositions for the isolation and/or stabilisation of nucleic acids in biological materials |
08/09/2011 | CA2409209C Chimeric arterivirus-like particles |
08/09/2011 | CA2407415C Chondroitin synthase gene and methods of making and using same |
08/09/2011 | CA2405958C Hybrid glycosylated products and their production and use |
08/09/2011 | CA2394470C Methods of assaying for compounds that inhibit premature translation termination and nonsense-mediated rna decay |
08/09/2011 | CA2380058C Novel peptides |
08/09/2011 | CA2370738C Uteroglobin in the treatment of iga mediated autoimmune disorders |
08/09/2011 | CA2370515C Methods and means for delivering inhibitory rna to plants and applications thereof |
08/09/2011 | CA2370278C Chimeric lyssavirus nucleic acids and polypeptides |
08/09/2011 | CA2367360C Insulin-like growth factor binding protein-4 protease |
08/09/2011 | CA2366462C Two-step immunization procedure against chlamydia infection |
08/09/2011 | CA2363297C Engineering intracellular sialylation pathways |
08/09/2011 | CA2354607C Method for detecting and/or quantifying a known function from a nucleic acid sample |
08/09/2011 | CA2350340C B-cell epitopes of hsp65 and uses thereof |
08/09/2011 | CA2333016C Xenobiotic related induction of gene expression |
08/09/2011 | CA2332115C Aav structural protein, its preparation and use |
08/09/2011 | CA2302809C Membrane virus host range mutations and their uses as vaccine substrates |
08/09/2011 | CA2291721C Ribosome complexes as selection particles for in vitro display and evolution of proteins |
08/09/2011 | CA2267210C Method of stabilizing useful protein and useful protein composition |
08/09/2011 | CA2267068C Renilla luciferase and green fluorescent protein fusion genes |
08/09/2011 | CA2261158C Prolactin receptor gene as a genetic marker for increased litter size in pigs |
08/09/2011 | CA2253240C Hereditary hemochromatosis gene |
08/09/2011 | CA2205075C Reagent and method for inhibition of n-ras expression |
08/09/2011 | CA2146328C C-c ckr-1, c-c chemokine receptor |
08/04/2011 | WO2011094738A1 Enhanced efficiency of induced pluripotent stem cell generation |
08/04/2011 | WO2011094683A2 Method of identifying myelodysplastic syndromes |
08/04/2011 | WO2011094593A2 Novel lowered affinity antibodies and methods of marking the same |
08/04/2011 | WO2011094584A2 Method and system for purifying and quantitating proteins using heme fusion tags |
08/04/2011 | WO2011094530A2 NOVEL β-GLUCOSIDASE AND USES THEREOF |
08/04/2011 | WO2011094421A1 Sorghum transformation |
08/04/2011 | WO2011094356A2 Methods and kits used in the detection of fungus |
08/04/2011 | WO2011094335A2 Microrna signatures predicting responsiveness to anti-her2 therapy |
08/04/2011 | WO2011094259A2 Cd127 binding proteins |
08/04/2011 | WO2011094205A1 Hppd-inhibitor herbicide tolerance |
08/04/2011 | WO2011094199A1 Polynucleotide and polypeptide sequences associated with herbicide tolerance |
08/04/2011 | WO2011094198A1 A scalable manufacturing platform for viral vector purification and viral vectors so purified for use in gene therapy |
08/04/2011 | WO2011093932A2 Design of fibrinogen and fibrinogen derived products with reduced bacterial binding by using modified sequences of fibrinogen chains |
08/04/2011 | WO2011093606A2 Method and kit for detecting braf mutant using real-time pcr clamping on the basis of pna |
08/04/2011 | WO2011093509A1 Polynucleotide encoding acyl-coa synthetase homolog and method for using the same |
08/04/2011 | WO2011093485A1 Method for detection and quantification of hepatitis c virus, and polypeptide for use in the method |
08/04/2011 | WO2011093468A1 Transformation plasmid |
08/04/2011 | WO2011093467A1 Transformation plasmid |
08/04/2011 | WO2011093465A1 Transformation plasmid |
08/04/2011 | WO2011093393A1 Method for assessment of potential for development of dravet syndrome and use thereof |
08/04/2011 | WO2011093241A1 Method for producing chemicals by continuous fermentation |
08/04/2011 | WO2011093217A1 ANTI-Pandemic (H1N1) 2009 ANTIBODY AND IMMUNOASSAY METHOD USING SAME |
08/04/2011 | WO2011093187A1 Method for producing pyripyropene derivative by enzymatic process |
08/04/2011 | WO2011093186A1 Nucleic acid structure containing a pyripyropene biosynthesis gene cluster and a marker gene |
08/04/2011 | WO2011093185A1 Method for manufacturing a pyripyropene |
08/04/2011 | WO2011093097A1 Anti-dll3 antibody |
08/04/2011 | WO2011092792A1 Specific mould detection microarray, and method of use for same |
08/04/2011 | WO2011092791A1 Specific mould detection system, specific mould detection method, and pcr reaction liquid |
08/04/2011 | WO2011092780A1 Nucleic acid analyzer, reaction device for nucleic acid analysis and substrate of reaction device for nucleic acid analysis |
08/04/2011 | WO2011092675A2 Molecular complex for targeting antigens towards cells comprising antigens and uses thereof for vaccination |
08/04/2011 | WO2011092538A1 Agents for carbon dioxide capture, agents for amine stabilization and methods of making agents for carbon dioxide capture and amine stabilization |
08/04/2011 | WO2011092347A1 Oligopeptidic compounds and uses thereof |
08/04/2011 | WO2011092242A1 Factor vii fusion polypeptides |
08/04/2011 | WO2011092234A1 Methods and compositions using fgf23 fusion polypeptides |
08/04/2011 | WO2011092029A1 Vaccinia virus mutants containing the major genomic deletions of mva |
08/04/2011 | WO2011091764A1 Genes encoding proteins able to enhance heat resistance of plants and microorganism and uses thereof |
08/04/2011 | WO2011091716A1 Epidermal growth factor receptor variant |
08/04/2011 | WO2011091565A1 Method for production of virus vector |
08/04/2011 | WO2011091562A1 Method for breeding transgenic animals with enhanced expression of porcine growth hormone |
08/04/2011 | WO2011073208A9 Modified ubiquitin proteins having a specific binding activity for the extradomain b of fibronectin |
08/04/2011 | WO2011070214A3 Conjugates and compositions for immunotherapy and anti-tumor treatment |
08/04/2011 | WO2011067745A3 Compositions and methods for enhancing plants resistance to abiotic stress |
08/04/2011 | WO2011064758A3 Fusion proteins of immunoglobulin fc and interferon- alpha |
08/04/2011 | WO2011064395A3 Inhibitors and antagonists of calcium channels in the treatment of asthma |
08/04/2011 | WO2011055916A3 Method for detecting the methylation of colon-cancer-specific methylation marker genes for colon cancer diagnosis |
08/04/2011 | WO2011053896A3 Hypoxia regulated conditionally silenced aav expressing angiogenic inducers |
08/04/2011 | WO2011041011A3 Carbonic anhydrase polypeptides and uses thereof |
08/04/2011 | WO2011040971A9 Generation of modified polymerases for improved accuracy in single molecule sequencing |
08/04/2011 | WO2011035030A3 Induction of neuronal differentiation in non-neuronal cells using a nucleic acid molecule |
08/04/2011 | WO2011031482A3 Treatment of 'iq motif containing gtpase activating protein' (iqgap) related diseases by inhibition of natural antisense transcript to iqgap |
08/04/2011 | WO2011031319A3 Rnai in budding yeast |
08/04/2011 | WO2011022725A3 Mimotopes of hiv and uses thereof |
08/04/2011 | WO2011017382A3 Nanofibers and morphology shifting micelles |
08/04/2011 | WO2011006165A3 Detecting multinucleotide repeats |
08/04/2011 | WO2011002924A3 Gaussia luciferase variant for high-throughput screening |
08/04/2011 | WO2010129799A3 Treatment of lipid transport and metabolism gene related diseases by inhibition of natural antisense transcript to a lipid transport and metabolism gene |
08/04/2011 | WO2010115052A3 Induced pluripotent stem cells |
08/04/2011 | US20110191915 Influenza virus immunizing epitope |
08/04/2011 | US20110191914 Targeted Integration and Stacking of DNA Through Homologous Recombination |
08/04/2011 | US20110191912 Promoter, promoter control elements, and combinations, and uses thereof |
08/04/2011 | US20110191911 Method for the alteration of plants using cle polypeptides/peptides |
08/04/2011 | US20110191910 Plants with altered root architecture, related constructs and methods involving genes encoding lectin protein kinase (lpk) polypeptides and homologs thereof |
08/04/2011 | US20110191908 Regulator for flowering time, transgenic plant transformed with the same, and method for regulating flowering time |
08/04/2011 | US20110191907 Flavonoid-3',5'-hydroxylase gene of commelina communis |
08/04/2011 | US20110191906 Marchantiales-derived unsaturated fatty acid synthetase genes and use of the same |
08/04/2011 | US20110191905 Modification of Fatty Acid Biosynthesis using Recombinant Diacylglycerol Acyltransferase Sequences from Rygrass (lolium) and Fescue (festuca) |